Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Sales (2019 - 2025)

Legend Biotech filings provide 7 years of Return on Sales readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.0%, changed 0.0% from a year prior.
  • Return on Sales hit 0.0% in Q4 2025 for Legend Biotech, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.03% in Q1 2023 to a low of 0.16% in Q2 2022.
  • Median Return on Sales over the past 5 years was 0.01% (2022), compared with a mean of 0.02%.
  • Biggest five-year swings in Return on Sales: decreased -12bps in 2022 and later grew 13bps in 2023.
  • Legend Biotech's Return on Sales stood at 0.02% in 2021, then tumbled by -126bps to 0.05% in 2022, then surged by 100bps to 0.0% in 2023, then surged by 15662506bps to 0.0% in 2024, then tumbled by -109bps to 0.0% in 2025.
  • The last three reported values for Return on Sales were 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.